Innoviva (INVA) Prepaid Assets (2010 - 2026)
Innoviva's (INVA) quarterly Prepaid Assets came in at $24.8 million in Q1 2026, up 7836.74% YoY from $313000.0 in Q1 2025, and up 1417.53% on a QoQ basis from $1.6 million in Q4 2025.
Analysis
Innoviva (INVA) Prepaid Assets (2010 - 2026) Analysis & Trends
Innoviva (INVA) has 17 years of Prepaid Assets data on file, last reported at $24.8 million in Q1 2026.
- Quarterly Prepaid Assets rose 7836.74% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.8 million (up 7836.74% YoY) and the FY2025 annual result came in at $1.6 million, down 92.23% from the prior year.
- Prepaid Assets rose to $24.8 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $24.8 million in Q1 2026 to a low of $181000.0 in Q2 2025.
- A 5-year average of $8.6 million and a median of $2.9 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2025 — Prepaid Assets sank 97.87% — and 2026, when it jumped 7836.74%.
- Tracing INVA's Prepaid Assets over 5 years: stood at $2.9 million in 2022, then jumped by 637.47% to $21.6 million in 2023, then decreased by 2.62% to $21.1 million in 2024, then plunged by 92.23% to $1.6 million in 2025, then soared by 1417.53% to $24.8 million in 2026.
- The last three Prepaid Assets figures came in at $24.8 million (Q1 2026), $1.6 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.41 Mn |
| Mar 31, 2026 | 24.84 Mn |
| Dec 31, 2025 | 26.72 Mn |
| Sep 30, 2025 | 19.42 Mn |
| Jun 30, 2025 | 16.61 Mn |
| Mar 31, 2025 | 15.41 Mn |
| Dec 31, 2024 | 21.06 Mn |
| Sep 30, 2024 | 12.65 Mn |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 16.55 Mn |
| Dec 31, 2023 | 21.63 Mn |
| Sep 30, 2023 | 14.73 Mn |
| Jun 30, 2023 | 20.54 Mn |
| Mar 31, 2023 | 24.12 Mn |
| Dec 31, 2022 | 29.56 Mn |
| Sep 30, 2022 | 7.93 Mn |
| Jun 30, 2022 | 3.95 Mn |
| Mar 31, 2022 | 5.58 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 542,000.00 |